Works cited by this work

172 works

Work: A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

Silymarin preconditioning protected insulin resistant rats from liver ischemia-reperfusion injury: role of endogenous H2S
N. Younis, Mohamed A. Shaheen, Mona F. Mahmoud
Article20163 citations
ABI
Modulatory effect of silymarin on nuclear factor-erythroid-2-related factor 2 regulated redox status, nuclear factor-κB mediated inflammation and apoptosis in experimental gastric ulcer
Walaa A. Keshk, Samer Zahran, Mohamed Katary +1
Article20173 citations
ABI
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
Abeer Alanazi, Laila M. Fadda, Ahlam M. Alhusaini +3
Article20203 citations
ABI
Evaluation of oral nano-silymarin formulation efficacy on prevention of radiotherapy induced mucositis: A randomized, double-blinded, placebo-controlled clinical trial
Sare Hosseini, Sina Rezaei, M.R. Niazi Moghadam +2
Article20213 citations
ABI
A review on the mechanisms of the effect of silymarin in milk thistle ( Silybum marianum ) on some laboratory animals
Roshanak Khazaei, Alireza Seidavi, Mehrdad Bouyeh
Review article20213 citations
ABI
Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation
Santosh K. Katiyar, Anshu M. Roy, Manjeshwar Shrinath Baliga
Article20053 citations
ABI
Silymarin Suppresses TNF-Induced Activation of NF-κB, c-Jun N-Terminal Kinase, and Apoptosis
Sunil K. Manna, Asok Mukhopadhyay, Nguyen T. Van +1
Article19993 citations
ABI
The Global Burden of Cancer 2013
Christina Fitzmaurice, Daniel Dicker, Amanda Pain +97
ArticleGlobal Cancer Incidence and ScreeningJAMA Oncology20152 citations
ABI
Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage
Elif Tatlıdede, Özer Şehırlı, Ayliz Velioğlu‐Öğünç +5
Article20092 citations
ABI
Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway
Xian Zhong, Yongliang Zhu, Qinghua Lu +3
Article20062 citations
ABI
Amelioration of doxorubicin-induced cardiotoxicity by resveratrol
Sameer Alharthi, OHOUD M. ALARABI, Wafaa S. Ramadan +5
Article20142 citations
ABI
Inhibition of T-Cell Inflammatory Cytokines, Hepatocyte NF-κB Signaling, and HCV Infection by Standardized Silymarin
Stephen J. Polyak, Chihiro Morishima, Margaret C. Shuhart +3
Article20072 citations
ABI
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Dinesh Vyas, Gieric Laput, Arpita Vyas
Review article20142 citations
ABI
Comparative studies of polydatin and resveratrol on mutual transformation and antioxidative effect in vivo
Huilin Wang, Jianping Gao, Yu-Liang Han +4
Article20152 citations
ABI
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia, Carlo G. Tocchetti, Kathleen L. Gabrielson +3
Review article20122 citations
ABI
Predictive value of p53, Bcl2 and bax in the radiotherapy of head and neck cancer
Orsolya Csuka, Éva Remenár, Krísztina Koronczay +2
Article19972 citations
ABI
In VitroAntimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin
Dayanne Rakelly de Oliveira, Saulo Relison Tintino, Maria Flaviana Bezerra Morais‐Braga +5
Article20152 citations
ABI
Role of p53, Bax, p21, and DNA-PKcs in radiation sensitivity of HCT-116 cells and xenografts
Sergio Huerta, Xiaohuan Gao, Seán Dineen +3
Article20132 citations
ABI
Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53
Chi Zhang, Yansheng Feng, Shuxin Qu +6
Article20112 citations
ABI
Silybin and silymarin - new effects and applications
Vladimír Křen, Daniela Walterová
Review article20052 citations
ABI
Resveratrol protects cardiomyocytes from doxorubicin-induced apoptosis through the AMPK/P53 pathway
Mi‐Hua Liu, Xiao‐Long Lin, Dongming Guo +7
Article20152 citations
ABI
Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes
Mi‐Hua Liu, Jian Shan, Jian Li +2
Article20162 citations
ABI
Photodynamic Synergistic Effect of Pheophorbide a and Doxorubicin in Combined Treatment against Tumoral Cells
Rubén Ruiz‐González, Paula Milán-Rois, Roger Bresolí‐Obach +4
Article20172 citations
ABI
Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity
Heba Samy Shoukry, Hania Ibrahim Ammar, Laila Ahmed Rashed +6
Article20172 citations
ABI
A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer
Chih‐Yang Huang, Da‐Tong Ju, Chih-Fen Chang +2
Review article20172 citations
ABI

Works cited by this work

Silymarin preconditioning protected insulin resistant rats from liver ischemia-reperfusion injury: role of endogenous H2S

Modulatory effect of silymarin on nuclear factor-erythroid-2-related factor 2 regulated redox status, nuclear factor-κB mediated inflammation and apoptosis in experimental gastric ulcer

Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats

Evaluation of oral nano-silymarin formulation efficacy on prevention of radiotherapy induced mucositis: A randomized, double-blinded, placebo-controlled clinical trial

A review on the mechanisms of the effect of silymarin in milk thistle ( <i>Silybum marianum</i> ) on some laboratory animals

Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome <i>c</i> release, and caspase activation

Silymarin Suppresses TNF-Induced Activation of NF-κB, c-Jun N-Terminal Kinase, and Apoptosis

The Global Burden of Cancer 2013

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway

Amelioration of doxorubicin-induced cardiotoxicity by resveratrol

Inhibition of T-Cell Inflammatory Cytokines, Hepatocyte NF-κB Signaling, and HCV Infection by Standardized Silymarin

Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis

Comparative studies of polydatin and resveratrol on mutual transformation and antioxidative effect in vivo

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Predictive value of p53, Bcl2 and bax in the radiotherapy of head and neck cancer

<i>In Vitro</i>Antimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin

Role of p53, Bax, p21, and DNA-PKcs in radiation sensitivity of HCT-116 cells and xenografts

Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53

Silybin and silymarin - new effects and applications

Resveratrol protects cardiomyocytes from doxorubicin-induced apoptosis through the AMPK/P53 pathway

Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes

Photodynamic Synergistic Effect of Pheophorbide a and Doxorubicin in Combined Treatment against Tumoral Cells

Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity

A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer